Lv11
58 积分 2024-10-20 加入
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
16天前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
1个月前
已完结
23O A randomized, phase III, double-blind study of chemoradiotherapy with or without pembrolizumab in patients with high-risk, locally advanced, cervical cancer (KEYNOTE-A18/ENGOT-cx11/GOG-3047): Results for patients enrolled in Asia
2个月前
已完结
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Treatment advances across the cervical cancer spectrum
2个月前
已完结
Emerging evidence for adapting radiotherapy to immunotherapy
2个月前
已完结
Cervical Cancer T-Cell Immune Response and Therapeutic Progress
2个月前
已完结
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study
2个月前
已完结
Immunotherapy in Cervical Cancer
2个月前
已完结
Exploiting temporal aspects of cancer immunotherapy
6个月前
已完结
皖公网安备34019202002308
